Forest Services
India's Accelerated TB Elimination Efforts: Overview and Significance
India, bearing the highest tuberculosis (TB) burden globally, reported 19 lakh (1.9 million) TB cases in 2022, marking a 15% decline from 2020 according to the National Tuberculosis Elimination Programme (NTEP) Annual Report 2023. The country aims to eliminate TB by 2025, five years ahead of the global Sustainable Development Goal (SDG) target of 2030. This accelerated timeline is driven by enhanced diagnostics, expanded treatment accessibility, and robust community engagement under the Ministry of Health and Family Welfare (MoHFW). The significance lies in India’s potential to set a global precedent for TB elimination in high-burden settings through integrated public health strategies and digital innovations.
UPSC Relevance
- GS Paper 2: Health Policies, Government Programmes (NTEP, Epidemic Diseases Act)
- GS Paper 3: Economic Development (Budgetary allocations, economic impact of TB)
- GS Paper 1: Social Issues (Public health, Right to Health under Article 21)
- Essay: Public Health and Disease Control in India
Legal and Constitutional Framework Supporting TB Elimination
Article 21 of the Indian Constitution implicitly guarantees the right to health as part of the right to life, which underpins the state’s obligation to provide TB care. The Epidemic Diseases Act, 1897 enables rapid governmental response to infectious diseases including TB. The National Tuberculosis Elimination Programme (NTEP), operational under MoHFW, supersedes the Revised National Tuberculosis Control Programme (RNTCP) and aligns with the TB (Prevention and Control) Rules, 2018 mandating notification of TB cases. The Rights of Persons with Disabilities Act, 2016 extends protections and support to TB patients experiencing disabilities. Landmark Supreme Court rulings such as Paschim Banga Khet Mazdoor Samity v. State of West Bengal (1996) reinforce health as a fundamental right, providing judicial backing for TB elimination efforts.
- Article 21: Right to health as part of right to life.
- Epidemic Diseases Act, 1897: Legal framework for infectious disease control.
- TB (Prevention and Control) Rules, 2018: Mandatory TB case notification.
- Rights of Persons with Disabilities Act, 2016: Supports TB patients with disabilities.
- Supreme Court rulings emphasize state responsibility for health.
Economic Dimensions of TB Control in India
The Union Budget 2023-24 allocated ₹2,300 crore (~USD 300 million) for TB control, reflecting increased fiscal commitment. The economic loss due to TB in India is estimated at USD 32 billion annually (WHO 2022), driven by morbidity, mortality, and productivity decline. The global TB diagnostics market is projected to reach USD 3.7 billion by 2025, with India contributing significantly due to domestic demand for advanced diagnostics like CBNAAT. Private sector engagement under NTEP has improved treatment adherence by 20%, reducing strain on public health infrastructure and lowering overall economic burden.
- ₹2,300 crore allocated in 2023-24 for TB control by Government of India.
- Estimated USD 32 billion annual economic loss due to TB (WHO 2022).
- India’s demand fuels global TB diagnostics market growth to USD 3.7 billion by 2025.
- Private sector engagement increased treatment adherence by 20%.
- Enhanced diagnostics reduce treatment delays and associated costs.
Institutional Architecture and Technological Innovations
The National Tuberculosis Elimination Programme (NTEP) is the central implementing agency, evolving from the Revised National Tuberculosis Control Programme (RNTCP) which introduced the DOTS strategy. The Central TB Division within MoHFW formulates policies and oversees program implementation. The Indian Council of Medical Research (ICMR) spearheads TB research and diagnostics development, including deployment of CBNAAT (Cartridge Based Nucleic Acid Amplification Test) which increased rapid diagnosis by 40% (ICMR 2023). The Nikshay Platform, a digital TB patient management system, enables real-time case tracking and treatment adherence monitoring, enhancing program efficiency.
- NTEP: Implements national TB control and elimination strategies.
- RNTCP: Predecessor program, established DOTS.
- ICMR: Research and diagnostics innovation (e.g., CBNAAT).
- Nikshay Platform: Digital real-time TB patient management.
- Central TB Division: Policy formulation and oversight.
Data-Driven Progress and Targets Under NTEP
India’s TB incidence and mortality reduction targets under the National Strategic Plan 2020-25 are ambitious: an 80% reduction in incidence and 90% reduction in mortality by 2025 compared to 2015. Treatment success rates improved from 81% in 2019 to 86% in 2022. Active case finding screened over 2.5 crore people in 2022, facilitating early diagnosis. Private sector TB notifications increased by 30% in 2022 due to mandatory notification rules. These data points reflect tangible progress towards elimination.
- TB incidence reduction target: 80% by 2025 (vs 2015 baseline).
- Mortality reduction target: 90% by 2025.
- Treatment success rate: 86% in 2022, up from 81% in 2019.
- 2.5 crore people screened under active case finding in 2022.
- 30% increase in private sector TB notifications in 2022.
Comparative Analysis: India and South Africa TB Strategies
| Aspect | India | South Africa |
|---|---|---|
| TB Burden | Highest globally; 1.9 million cases in 2022 | High, complicated by HIV-TB co-infection |
| Diagnostic Tools | Wide use of CBNAAT; digital tracking via Nikshay | Adoption of GeneXpert; community health worker models |
| Program Scale | National coverage with integration of private sector | Focused on high-risk groups; HIV co-management |
| Outcomes | 15% decline in cases since 2020; treatment success 86% | Improved but challenged by HIV co-infection and resource constraints |
| Innovation | Digital real-time data systems; mandatory notification | Community engagement; integrated HIV-TB care |
Critical Gaps in India’s TB Elimination Strategy
Despite biomedical advances, social determinants such as malnutrition, poverty, and stigma remain under-addressed. These factors contribute to delayed diagnosis and poor treatment adherence. Policy frameworks predominantly focus on diagnostics and treatment, with insufficient integration of social support mechanisms. Stigma reduction and nutritional supplementation programs require scaling to ensure equitable access and sustained outcomes.
- Malnutrition and poverty impede TB control effectiveness.
- Stigma delays diagnosis and reduces treatment adherence.
- Social support and nutritional programs are under-integrated.
- Biomedical focus overshadows social determinants in policy.
- Need for multisectoral approaches beyond health sector.
Significance and Way Forward
- India’s 2025 elimination target, if achieved, will be a global milestone, demonstrating feasibility in high-burden settings.
- Scaling private sector engagement and mandatory notification must continue to close notification gaps.
- Expansion of digital platforms like Nikshay should be complemented with data privacy safeguards.
- Addressing social determinants through inter-ministerial coordination (Health, Women & Child Development, Social Justice) is critical.
- Investment in research for drug-resistant TB and co-morbidities must be sustained.
PRACTICE QUESTIONS
- CBNAAT is a molecular test that has increased rapid TB diagnosis by 40% in India.
- Sputum microscopy remains the most sensitive diagnostic tool for TB detection.
- The Nikshay platform integrates diagnostic data for real-time patient management.
Which of the above statements is/are correct?
- India aims to eliminate TB by 2030, in line with global SDG targets.
- The National Strategic Plan 2020-25 targets an 80% reduction in TB incidence by 2025 compared to 2015.
- TB mortality reduction target under the plan is 90% by 2025.
Which of the above statements is/are correct?
What is the role of the Nikshay platform in India’s TB elimination efforts?
Nikshay is a digital TB patient management system launched by NTEP that enables real-time tracking of TB cases, treatment adherence monitoring, and data analytics. It integrates notifications from both public and private sectors, improving case management and program transparency.
How has the COVID-19 pandemic impacted TB control in India?
COVID-19 disrupted TB services due to lockdowns and resource diversion, causing delays in diagnosis and treatment. However, post-pandemic recovery efforts under NTEP have accelerated active case finding and digital monitoring to mitigate these setbacks.
What legal provisions mandate TB case notification in India?
The TB (Prevention and Control) Rules, 2018, under the Epidemic Diseases Act, 1897, make it mandatory for all healthcare providers to notify TB cases to the government, ensuring comprehensive surveillance and treatment follow-up.
Why is private sector engagement crucial in India’s TB elimination?
Approximately 50% of TB patients initially seek care in the private sector. Engaging private providers through mandatory notification and treatment adherence support improves case detection, reduces transmission, and lessens public health system burden.
What are the main social determinants hindering TB elimination in India?
Malnutrition, poverty, overcrowding, and stigma delay diagnosis and reduce treatment adherence. These factors require multisectoral interventions beyond biomedical approaches to achieve sustainable TB elimination.
About LearnPro Editorial Standards
LearnPro editorial content is researched and reviewed by subject matter experts with backgrounds in civil services preparation. Our articles draw from official government sources, NCERT textbooks, standard reference materials, and reputed publications including The Hindu, Indian Express, and PIB.
Content is regularly updated to reflect the latest syllabus changes, exam patterns, and current developments. For corrections or feedback, contact us at admin@learnpro.in.